An exploratory study to evaluate efficacy and safety of frequent Transcutaneous Electrical Stimulation for Leber Hereditary Optic Neuropathy

Abstract Electrical stimulation (ES) may be effective for intractable retinal or optic nerve diseases. We studied frequent transcutaneous ES in a single-center, single-arm prospective study in patients with Leber hereditary optic neuropathy (LHON) who carry the mitochondrial (mt) 11778 G > A muta...

Full description

Saved in:
Bibliographic Details
Main Authors: Fumio Takano, Kaori Ueda, Takuji Kurimoto, Mina Arai, Takayuki Nagai, Yuko Yamada-Nakanishi, Makoto Nakamura
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-89076-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823862300863365120
author Fumio Takano
Kaori Ueda
Takuji Kurimoto
Mina Arai
Takayuki Nagai
Yuko Yamada-Nakanishi
Makoto Nakamura
author_facet Fumio Takano
Kaori Ueda
Takuji Kurimoto
Mina Arai
Takayuki Nagai
Yuko Yamada-Nakanishi
Makoto Nakamura
author_sort Fumio Takano
collection DOAJ
description Abstract Electrical stimulation (ES) may be effective for intractable retinal or optic nerve diseases. We studied frequent transcutaneous ES in a single-center, single-arm prospective study in patients with Leber hereditary optic neuropathy (LHON) who carry the mitochondrial (mt) 11778 G > A mutation. A 30-min ES was applied to either eye every other day for 12 weeks. The primary outcome was the difference in the logarithm of the minimum angle of resolution (LogMAR) at baseline and 1 week after completion of ES treatment. The secondary outcomes included changes in visual field; LogMAR; critical flicker frequency; and inner retinal thickness. Safety endpoints included the corneal endothelial cell density and complications during ES. Fourteen patients participated in the study; four dropped out. The median (interquartile range) LogMAR values before stimulation and 1, 4, and 8 weeks after ES were 1.60 (1.45–1.80), 1.70 (1.35–1.80), 1.60 (1.43–1.73), and 1.50 (1.43–1.73), respectively, indicating no significant improvement (primary outcome: Wilcoxon’s signed rank test, p = 1.000, secondary outcome: Friedman test, p = 0.229). There were no improvements in any secondary efficacy endpoints and no complications. In conclusion, frequent transcutaneous ES did not improve visual acuity in patients with LHON carrying the mt11778 G > A mutation.
format Article
id doaj-art-5d358aaf9bb040eaae7ca9c74ecc6523
institution Kabale University
issn 2045-2322
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-5d358aaf9bb040eaae7ca9c74ecc65232025-02-09T12:33:05ZengNature PortfolioScientific Reports2045-23222025-02-0115111210.1038/s41598-025-89076-zAn exploratory study to evaluate efficacy and safety of frequent Transcutaneous Electrical Stimulation for Leber Hereditary Optic NeuropathyFumio Takano0Kaori Ueda1Takuji Kurimoto2Mina Arai3Takayuki Nagai4Yuko Yamada-Nakanishi5Makoto Nakamura6Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of MedicineDivision of Ophthalmology, Department of Surgery, Kobe University Graduate School of MedicineKurimoto Eye ClinicDivision of Ophthalmology, Department of Surgery, Kobe University Graduate School of MedicineDivision of Ophthalmology, Department of Surgery, Kobe University Graduate School of MedicineDivision of Ophthalmology, Department of Surgery, Kobe University Graduate School of MedicineDivision of Ophthalmology, Department of Surgery, Kobe University Graduate School of MedicineAbstract Electrical stimulation (ES) may be effective for intractable retinal or optic nerve diseases. We studied frequent transcutaneous ES in a single-center, single-arm prospective study in patients with Leber hereditary optic neuropathy (LHON) who carry the mitochondrial (mt) 11778 G > A mutation. A 30-min ES was applied to either eye every other day for 12 weeks. The primary outcome was the difference in the logarithm of the minimum angle of resolution (LogMAR) at baseline and 1 week after completion of ES treatment. The secondary outcomes included changes in visual field; LogMAR; critical flicker frequency; and inner retinal thickness. Safety endpoints included the corneal endothelial cell density and complications during ES. Fourteen patients participated in the study; four dropped out. The median (interquartile range) LogMAR values before stimulation and 1, 4, and 8 weeks after ES were 1.60 (1.45–1.80), 1.70 (1.35–1.80), 1.60 (1.43–1.73), and 1.50 (1.43–1.73), respectively, indicating no significant improvement (primary outcome: Wilcoxon’s signed rank test, p = 1.000, secondary outcome: Friedman test, p = 0.229). There were no improvements in any secondary efficacy endpoints and no complications. In conclusion, frequent transcutaneous ES did not improve visual acuity in patients with LHON carrying the mt11778 G > A mutation.https://doi.org/10.1038/s41598-025-89076-zElectrical stimulationLeber Hereditary Optic NeuropathyMitochondrial diseaseProspective studyVisual field
spellingShingle Fumio Takano
Kaori Ueda
Takuji Kurimoto
Mina Arai
Takayuki Nagai
Yuko Yamada-Nakanishi
Makoto Nakamura
An exploratory study to evaluate efficacy and safety of frequent Transcutaneous Electrical Stimulation for Leber Hereditary Optic Neuropathy
Scientific Reports
Electrical stimulation
Leber Hereditary Optic Neuropathy
Mitochondrial disease
Prospective study
Visual field
title An exploratory study to evaluate efficacy and safety of frequent Transcutaneous Electrical Stimulation for Leber Hereditary Optic Neuropathy
title_full An exploratory study to evaluate efficacy and safety of frequent Transcutaneous Electrical Stimulation for Leber Hereditary Optic Neuropathy
title_fullStr An exploratory study to evaluate efficacy and safety of frequent Transcutaneous Electrical Stimulation for Leber Hereditary Optic Neuropathy
title_full_unstemmed An exploratory study to evaluate efficacy and safety of frequent Transcutaneous Electrical Stimulation for Leber Hereditary Optic Neuropathy
title_short An exploratory study to evaluate efficacy and safety of frequent Transcutaneous Electrical Stimulation for Leber Hereditary Optic Neuropathy
title_sort exploratory study to evaluate efficacy and safety of frequent transcutaneous electrical stimulation for leber hereditary optic neuropathy
topic Electrical stimulation
Leber Hereditary Optic Neuropathy
Mitochondrial disease
Prospective study
Visual field
url https://doi.org/10.1038/s41598-025-89076-z
work_keys_str_mv AT fumiotakano anexploratorystudytoevaluateefficacyandsafetyoffrequenttranscutaneouselectricalstimulationforleberhereditaryopticneuropathy
AT kaoriueda anexploratorystudytoevaluateefficacyandsafetyoffrequenttranscutaneouselectricalstimulationforleberhereditaryopticneuropathy
AT takujikurimoto anexploratorystudytoevaluateefficacyandsafetyoffrequenttranscutaneouselectricalstimulationforleberhereditaryopticneuropathy
AT minaarai anexploratorystudytoevaluateefficacyandsafetyoffrequenttranscutaneouselectricalstimulationforleberhereditaryopticneuropathy
AT takayukinagai anexploratorystudytoevaluateefficacyandsafetyoffrequenttranscutaneouselectricalstimulationforleberhereditaryopticneuropathy
AT yukoyamadanakanishi anexploratorystudytoevaluateefficacyandsafetyoffrequenttranscutaneouselectricalstimulationforleberhereditaryopticneuropathy
AT makotonakamura anexploratorystudytoevaluateefficacyandsafetyoffrequenttranscutaneouselectricalstimulationforleberhereditaryopticneuropathy
AT fumiotakano exploratorystudytoevaluateefficacyandsafetyoffrequenttranscutaneouselectricalstimulationforleberhereditaryopticneuropathy
AT kaoriueda exploratorystudytoevaluateefficacyandsafetyoffrequenttranscutaneouselectricalstimulationforleberhereditaryopticneuropathy
AT takujikurimoto exploratorystudytoevaluateefficacyandsafetyoffrequenttranscutaneouselectricalstimulationforleberhereditaryopticneuropathy
AT minaarai exploratorystudytoevaluateefficacyandsafetyoffrequenttranscutaneouselectricalstimulationforleberhereditaryopticneuropathy
AT takayukinagai exploratorystudytoevaluateefficacyandsafetyoffrequenttranscutaneouselectricalstimulationforleberhereditaryopticneuropathy
AT yukoyamadanakanishi exploratorystudytoevaluateefficacyandsafetyoffrequenttranscutaneouselectricalstimulationforleberhereditaryopticneuropathy
AT makotonakamura exploratorystudytoevaluateefficacyandsafetyoffrequenttranscutaneouselectricalstimulationforleberhereditaryopticneuropathy